"Shouldn’t pay-for-delay agreements be a clear antitrust violation? According to a group of plaintiffs that include prominent HIV/AIDS advocates, the answer is yes."

https://www.theatlantic.com/ideas/archive/2023/06/pharmaceutical-generic-drugs-pay-for-delay/674410/